112 related articles for article (PubMed ID: 2885450)
1. Placebo-controlled, double-blind study of haemodilution in peripheral arterial disease.
Ernst E; Matrai A; Kollar L
Lancet; 1987 Jun; 1(8548):1449-51. PubMed ID: 2885450
[TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled, double-blind trial of hemodilution in peripheral occlusive arterial disease.
Ernst E; Matrai A; Kollar L
Angiology; 1989 May; 40(5):479-83. PubMed ID: 2468300
[TBL] [Abstract][Full Text] [Related]
3. Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication.
Yates CJ; Berent A; Andrews V; Dormandy JA
Lancet; 1979 Jul; 2(8135):166-8. PubMed ID: 89279
[TBL] [Abstract][Full Text] [Related]
4. A double-blind trial of Dextran-haemodilution vs. placebo in claudicants.
Ernst E; Kollar L; Matrai A
J Intern Med; 1990 Jan; 227(1):19-24. PubMed ID: 1688913
[TBL] [Abstract][Full Text] [Related]
5. Microcirculatory long-term effects after hypervolaemic and isovolaemic haemodilution in patients with intermittent claudication.
Höffkes HG; Ehrly AM
Presse Med; 1994 Apr; 23(14):657-60. PubMed ID: 8072963
[TBL] [Abstract][Full Text] [Related]
6. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
Ernst E; Kollar L; Matrai A
Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
[TBL] [Abstract][Full Text] [Related]
7. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
[TBL] [Abstract][Full Text] [Related]
8. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
9. Current therapy of peripheral obstructive arterial disease. The non-surgical approach.
De Felice M; Gallo P; Masotti G
Angiology; 1990 Jan; 41(1):1-11. PubMed ID: 2407152
[TBL] [Abstract][Full Text] [Related]
10. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb.
Kiesewetter H; Blume J; Jung F; Spitzer S; Wenzel E
J Intern Med; 1990 Feb; 227(2):107-14. PubMed ID: 1688914
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapeutical approaches to decreasing hematocrit and increasing claudication distance in diabetic patients with peripheral vascular disease.
Urge J; Strojil J; Utíkal P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):267-70. PubMed ID: 16601768
[TBL] [Abstract][Full Text] [Related]
12. [Ambulatory hemodilution therapy of peripheral arterial circulation disorders].
Wohlleben E; Wohlleben H; Voigt H; Köhler H
Z Gesamte Inn Med; 1981 Nov; 36(21):838-9. PubMed ID: 7331388
[TBL] [Abstract][Full Text] [Related]
13. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease.
Husmann M; Dörffler-Melly J; Kalka C; Diehm N; Baumgartner I; Silvestro A
J Vasc Surg; 2008 Nov; 48(5):1211-6. PubMed ID: 18771886
[TBL] [Abstract][Full Text] [Related]
14. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
[TBL] [Abstract][Full Text] [Related]
15. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
Delis KT; Nicolaides AN; Wolfe JH; Stansby G
J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
[TBL] [Abstract][Full Text] [Related]
16. A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation.
Hansen LL; Danisevskis P; Arntz HR; Hövener G; Wiederholt M
Br J Ophthalmol; 1985 Feb; 69(2):108-16. PubMed ID: 3966997
[TBL] [Abstract][Full Text] [Related]
17. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
Ehrly AM; Seebens H; Saeger-Lorenz K
Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
[TBL] [Abstract][Full Text] [Related]
18. Controlled trial of suloctidil in intermittent claudication.
Verhaeghe R; Van Hoof A; Beyens G
J Cardiovasc Pharmacol; 1981; 3(2):279-86. PubMed ID: 6166799
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal shockwave therapy for intermittent claudication: Medium-term outcomes from a double-blind randomised placebo-controlled pilot trial.
Green JL; Harwood AE; Smith GE; Das T; Raza A; Cayton T; Wallace T; Carradice D; Chetter IC
Vascular; 2018 Oct; 26(5):531-539. PubMed ID: 29722640
[TBL] [Abstract][Full Text] [Related]
20. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
